| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,193 |
6,701 |
$3.51M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,273 |
10,777 |
$3.22M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,508 |
4,144 |
$2.46M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,969 |
2,671 |
$267K |
| 71045 |
Radiologic examination, chest; single view |
3,574 |
3,290 |
$237K |
| 80053 |
Comprehensive metabolic panel |
8,363 |
7,505 |
$80K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
235 |
223 |
$80K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,319 |
8,213 |
$64K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
289 |
278 |
$57K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,707 |
2,450 |
$55K |
| 59025 |
Fetal non-stress test |
480 |
329 |
$54K |
| 99215 |
Prolong outpt/office vis |
252 |
223 |
$51K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
263 |
255 |
$48K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,645 |
1,471 |
$48K |
| 70450 |
Computed tomography, head or brain; without contrast material |
496 |
459 |
$46K |
| 87430 |
|
2,079 |
2,025 |
$42K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
856 |
809 |
$28K |
| 81001 |
|
6,757 |
6,257 |
$22K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,002 |
495 |
$20K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
298 |
279 |
$16K |
| 87070 |
|
1,493 |
1,451 |
$16K |
| 81025 |
|
1,202 |
1,140 |
$11K |
| 84484 |
|
1,671 |
1,196 |
$10K |
| 83690 |
|
1,559 |
1,441 |
$9K |
| 83880 |
|
623 |
557 |
$7K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
200 |
186 |
$4K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,006 |
920 |
$3K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
17 |
12 |
$3K |
| 87420 |
|
207 |
205 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
197 |
185 |
$3K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,891 |
2,785 |
$3K |
| 87428 |
|
102 |
99 |
$2K |
| CP007 |
|
67 |
64 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
701 |
537 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
15 |
13 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
107 |
92 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
28 |
25 |
$886.42 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
18 |
12 |
$814.57 |
| 87040 |
|
162 |
79 |
$740.84 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
98 |
93 |
$699.52 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
199 |
183 |
$695.50 |
| 87077 |
|
464 |
372 |
$688.44 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
508 |
452 |
$676.21 |
| 36415 |
Collection of venous blood by venipuncture |
9,582 |
8,325 |
$337.54 |
| 83605 |
|
125 |
94 |
$324.86 |
| 85610 |
|
207 |
178 |
$252.42 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
16 |
15 |
$247.43 |
| 85730 |
|
116 |
98 |
$212.16 |
| 84443 |
Thyroid stimulating hormone (TSH) |
40 |
39 |
$172.68 |
| 83735 |
|
45 |
40 |
$150.38 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
14 |
12 |
$146.01 |
| 82550 |
|
65 |
58 |
$125.83 |
| 87186 |
|
94 |
88 |
$74.76 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
17 |
15 |
$49.25 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
280 |
262 |
$17.00 |
| 82042 |
|
16 |
16 |
$6.54 |
| A9270 |
Non-covered item or service |
248 |
225 |
$0.00 |